Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity
Bryan A. Johnson, Adam Hage, Birte Kalveram, et al.
Journal of Virology (2019) Vol. 93, Iss. 22
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Bacillus sp.: A Remarkable Source of Bioactive Lipopeptides
Ariane Théatre, Alexis C. R. Hoste, Augustin Rigolet, et al.
Advances in biochemical engineering, biotechnology (2021), pp. 123-179
Closed Access | Times Cited: 25
Screening of a Bacillus subtilis strain producing both nattokinase and milk-clotting enzyme and its application in fermented milk with thrombolytic activity
Xuan Zhang, Yanjun Tong, Jing Wang, et al.
Journal of Dairy Science (2021) Vol. 104, Iss. 9, pp. 9437-9449
Open Access | Times Cited: 24
Role of Probiotic Bacilli in Developing Synbiotic Food: Challenges and Opportunities
Carolina Szlufman, Moshe Shemesh
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 23
Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro
Mami Oba, Rongduo Wen, Akatsuki Saito, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 570, pp. 21-25
Open Access | Times Cited: 23
Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential
Hui Xiang, Qiping Liu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 47, pp. 6689-6701
Open Access | Times Cited: 18
Microbiota as a potentially-modifiable factor influencing COVID-19
Vu L. Ngo, Andrew T. Gewirtz
Current Opinion in Virology (2021) Vol. 49, pp. 21-26
Open Access | Times Cited: 19
The influenza virus RNA polymerase as an innate immune agonist and antagonist
Elizaveta Elshina, Aartjan J. W. te Velthuis
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 23, pp. 7237-7256
Open Access | Times Cited: 18
Surfactin Bacterial Antiviral Lipopeptide Blocks In Vitro Replication of SARS-CoV-2
Sérgio Crovella, Lucas Carvalho de Freitas, Luisa Zupin, et al.
Applied Microbiology (2022) Vol. 2, Iss. 3, pp. 680-687
Open Access | Times Cited: 13
Association of SARS-CoV-2 and Polypharmacy with Gut–Lung Axis: From Pathogenesis to Treatment
Jonaid Ahmad Malik, Sakeel Ahmed, Zahid Yaseen, et al.
ACS Omega (2022) Vol. 7, Iss. 38, pp. 33651-33665
Open Access | Times Cited: 13
Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean Red Ginseng
Jeonghui Moon, Younghun Jung, Seokoh Moon, et al.
Journal of Ginseng Research (2022) Vol. 47, Iss. 1, pp. 123-132
Open Access | Times Cited: 10
The Synthetic Peptide GA-Hecate and Its Analogs Inhibit Multiple Steps of the Chikungunya Virus Infection Cycle In Vitro
Gabriela Miranda Ayusso, Paulo R. S. Sanches, Tamara Carvalho, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1389-1389
Open Access | Times Cited: 5
Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus
Xu Cao, Lan Huang, Min Tang, et al.
Virulence (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Added Value of Biophysics to Study Lipid-Driven Biological Processes: The Case of Surfactins, a Class of Natural Amphiphile Molecules
Guillaume Gilliard, Aurélien L. Furlan, Willy Smeralda, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13831-13831
Open Access | Times Cited: 7
Transkingdom Interactions Important for the Pathogenesis of Human Viruses
Andrew T. Nishimoto, Nicholas Wohlgemuth, Jason W. Rosch, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. Supplement_3, pp. S201-S208
Open Access | Times Cited: 6
Influence of inorganic and organic counter-cations on the surface properties and self-assembly of cyclic lipopeptide surfactin
Toshiaki Taira, Satohiro Yanagisawa, Tomohiro Imura
Colloids and Surfaces A Physicochemical and Engineering Aspects (2021) Vol. 626, pp. 126973-126973
Closed Access | Times Cited: 6
Elucidation of lipopeptide biosurfactants responsible for the larvicidal activity of Bacillus velezensis PHP1601 towards Lucilia cuprina larvae
Danvir Rajesh Ramesar, C.H. Hunter
Biocontrol Science and Technology (2023) Vol. 33, Iss. 8, pp. 772-787
Closed Access | Times Cited: 2
Perturbation of Alphavirus and Flavivirus Infectivity by Components of the Bacterial Cell Wall
Lana Langendries, Sofie Jacobs, Rana Abdelnabi, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 4
Network Topology of Biological Aging and Geroscience-Guided Approaches to COVID-19
Alan Landay, Jenna M. Bartley, Dishary Banerjee, et al.
Frontiers in Aging (2021) Vol. 2
Open Access | Times Cited: 5
Isolation and Identification of Lipopeptides of Bacillus subtilis 26D
Е. А. Черепанова, I. V. Galyautdinov, Г. Ф. Бурханова, et al.
Applied Biochemistry and Microbiology (2021) Vol. 57, Iss. 5, pp. 636-642
Closed Access | Times Cited: 5
Current understanding of gut microbiota in tackling COVID-19
S.H. Sumathi, Suganya Kanmani, K. Swathi, et al.
Annals of Phytomedicine An International Journal (2021) Vol. 10, Iss. Sp-Issue1 (COVID-19): S4-S12
Open Access | Times Cited: 4
Novel ionophores active against La Crosse virus identified through rapid antiviral screening
Zachary J. Sandler, Michelle N. Vu, Vineet D. Menachery, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 3
Identification of surfactin as an anti-severe fever with thrombocytopenia syndrome virus multi-target compound extracted from the culture broth of marine microbes
Shuzo Urata, Jun Takouda, Yoshihiro Watanabe, et al.
Frontiers in Virology (2023) Vol. 2
Open Access | Times Cited: 1
New Ways to Protect the Host from SARS-CoV-2? Lung Microbiome Metabolites Inhibit STAT3 and Modulate the Immunological Network
Jency Roshni, Mahema Sivakumar, Faris Ahmed Bahammam, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 5, pp. 237-244
Closed Access | Times Cited: 1
Alkyl Derivatives of Perylene Photosensitizing Antivirals: Towards Understanding the Influence of Lipophilicity
Igor E. Mikhnovets, Jiří Holoubek, Irina S. Panina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16483-16483
Open Access | Times Cited: 1
Selected lipopeptides of Bacillus as plausible inhibitors of SARS-COV-2 chymotrypsin-like protease 3CLPro: an in-silico analysis
S. P. Sen, Saikat Banerjee, Atreyee Ghosh, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 2

Scroll to top